Projects per year
Abstract
When mammalian cells detect a viral infection, they initiate a type I Interferon (IFNs) response as part of their innate immune system. This antiviral mechanism is conserved in virtually all cell types, except for embryonic stem cells (ESCs) and oocytes which are intrinsically incapable of producing IFNs. Despite the importance of the IFN response to fight viral infections, the mechanisms regulating this pathway during pluripotency are still unknown. Here we show that, in the absence of miRNAs, ESCs acquire an active IFN response. Proteomic analysis identified MAVS, a central component of the IFN pathway, to be actively silenced by miRNAs and responsible for suppressing IFN expression in ESCs. Furthermore, we show that knocking out a single miRNA, miR-673, restores the antiviral response in ESCs through MAVS regulation. Our findings suggest that the interaction between miR-673 and MAVS acts as a switch to suppress the antiviral IFN during pluripotency and present genetic approaches to enhance their antiviral immunity.
Original language | English |
---|---|
Article number | e44171 |
Number of pages | 19 |
Journal | eLIFE |
Volume | 8 |
DOIs | |
Publication status | Published - 23 Apr 2019 |
Keywords / Materials (for Non-textual outputs)
- chromosomes
- gene expression
- mouse
- regenerative medicine
- stem cells
Fingerprint
Dive into the research topics of 'MicroRNA-deficient mouse embryonic stem cells acquire a functional interferon response'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Antiviral defence mechanisms: small RNAs versus Interferon pathway
Macias Ribela, S. (Principal Investigator)
1/01/16 → 31/12/21
Project: Research
Profiles
-
Sara Macias Ribela
- School of Biological Sciences - Wellcome Senior Research Fellow
Person: Academic: Research Active